click here to return to homepage
 
 

Acceava®, BinaxNOW®, Clearview®, RUBELLA-plus® are registered trademarks of the Inverness Medical family of companies

More Information

Rubella-plus

Rubella-plus® is an immunochromatographic assay for the qualitative detection of Rubella antibody (IgG) in human serum or plasma.

Clearly different

Rubella-plus® provides simple, accurate detection of rubella antibodies.

  • Fast: results available in just 15 minutes

  • Easy: no special training or rotator needed

  • Reliable: detects antibodies at a level greater than or equal to 10 IU/mL

  • Flexible: can be used with either serum or plasma samples

Clearly better

The rapid, reliable results provided by Rubella-plus can lead to improved patient care. Early detection in women of child-bearing age may prevent the transmission of the disease to unborn children

Rubella

Add sample and developer.
Add 10 µL serum or plasma to sample window S.
Add 3 to 4 drops of developer solution to window D.

Rubella Result Window

Read results.
Results appear in 6-15 minutes. For full instructions, see package insert.


About Rubella 

Rubella (also called German measles or 3-day measles) is a disease caused by the rubella virus. Rubella spreads from person to person through the air (often through close contact such as talking, coughing, or sneezing) and is moderately contagious.

Although rubella can strike people of all ages, it poses the greatest danger to unborn babies. Congenital rubella syndrome (CRS) occurs when the rubella virus attacks a developing fetus. Up to 85% of infants infected during the first trimester will be born with birth defects, including deafness, blindness, heart defects, and mental retardation.1 Miscarriages are also common.2

Fortunately, due to widespread immunization with a rubella vaccine, rubella and CRS are now uncommon in the U.S.1 Rubella vaccine is often given together with measles and mumps vaccines as part of an MMR shot.

Reference

  1. Immunization Action Coalition. Vaccine Information for the Public and Health Professionals: Rubella Questions and Answers. Available at: http://www.vaccineinformation.org/rubella/qandadis.asp. Accessed April 21, 2005.

  2. Centers for Disease Control. Parents Guide to Childhood Immunization: Rubella (German Measles). Available at: http://www.cdc.gov/nip/publications/Parents-Guide/pg-rubella.pdf. Accessed April 21, 2005.

Specifications
Order No. 84R2
Qty: 30 Tests
CPT*: 86762, 86318, 87899
CLIA: Non-waived
Contact: (800) 257-9525
Rubella Plus Test Kit
Useful Downloads 
Product Brochure
Reimbursement
Look up CPT & ICD-9 codes, coverage policies, and state by state Medicare reimbursement information at: www.codemap.com/
inverness
 or call the CodeMap Hotline: 847.381.5465 x5, or email: customerservice@
codemap.com


*It is always the provider's responsibility to establish appropriate coding & charges.
For technical information including: CLSI procedures, Material Safety Data Sheets (MSDS) and package inserts,
call Technical Services at 800-257-9525





Please note that individual products may have different specifications in various markets. Also, some products may not be available in all markets worldwide. The products on this website are available in the United States of America.